Thomas J Ridge
CIK 1320299 · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.82M
Companies
9
Total Filings
143
Lifetime Open-Market Net
-$908.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYX | Director | 1,068,193 | $1.06 | $1.13M | $0 | 11 | 2026-04-02 |
| HSY | Director | 35,884 | $181.66 | $6.52M | -$30.4K | 67 | 2018-04-03 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Director | — | — | — | $0 | 2 | 2017-11-06 |
| LIFELOCK, INC. (LOCK) Delisted | Director | 38,861 | — | — | -$998.0K | 7 | 2016-05-06 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Director | 24,306 | — | — | $0 | 2 | 2016-03-04 |
| EXELON CORP (EXCw) Delisted | Director | 19,351 | — | — | $0 | 29 | 2014-01-02 |
| BRIGHTPOINT INC (CELL) Delisted | Director | 0 | $1.00 | $0 | $120.0K | 3 | 2012-10-16 |
| VG | Director | 89,441 | $13.08 | $1.17M | $0 | 14 | 2010-04-05 |
| HD | Director | — | $328.39 | — | $0 | 7 | 2007-05-25 |
Recent Filings · Page 2 of 15
143 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-16 | SKYX | Grant (A) | +5,000 | $0 | EDGAR |
| 2018-04-03 | HSY | Grant (A) | +138 | $0 | EDGAR |
| 2018-03-15 | HSY | Grant (A) | +116 | $12.5K | EDGAR |
| 2018-01-03 | HSY | Grant (A) | +339 | $0 | EDGAR |
| 2017-12-15 | HSY | Grant (A) | +116 | $12.6K | EDGAR |
| 2017-11-06 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-03 | HSY | Grant (A) | +345 | $0 | EDGAR |
| 2017-09-18 | HSY | Grant (A) | +116 | $12.5K | EDGAR |
| 2017-07-05 | HSY | Grant (A) | +349 | $0 | EDGAR |
| 2017-06-15 | HSY | Grant (A) | +115 | $12.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.